<DOC>
	<DOCNO>NCT00588029</DOCNO>
	<brief_summary>The purpose study collect blood sample patient breast disease ( case ) individual without breast cancer ( control ) may use research purpose . These blood sample use researcher Memorial Sloan-Kettering Cancer Center study cause breast cancer , well effective way prevent , diagnose , treat breast cancer .</brief_summary>
	<brief_title>Collection Tissue , Blood , Cells Be Used For Studying Causes , Prevention , Diagnosis , Treatment Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>For acquisition exist breast cancer tissue specimens MSKCC Tissue Procurement Service , criterion pathologicallyconfirmed diagnosis invasive breast cancer availability correspond nonmalignant tissue case . For prospective acquisition blood saliva control subject without breast cancer , eligibility criterion include : Any patient previous diagnosis invasive breast cancer undergoes palliative procedure relate presence pleural effusion eligible pleural fluid collection aspect protocol . Any female patient , female age 18 accompany patient care physician Department Urology , Department Surgery , Department Medicine . Subjects history preinvasive ( carcinoma situ ) invasive breast cancer . Subjects eligible without regard racial , ethnic status . Attending physician authorize obtain informed consent may exercise discretion exclude individual appropriate medical ( e.g. , mentally impaired ) reason . For prospective acquisition blood , saliva , pleural fluid cerebrospinal fluid patient suspect breast cancer carcinoma insitu , eligibility criterion include : Any patient MSKCC previously confirm suspected diagnosis malignant premalignant ( e.g. , carcinoma situ ) breast disease eligible inclusion blood acquisition aspect protocol . Any patient previous diagnosis invasive breast cancer undergoes palliative procedure relate presence pleural effusion eligible pleural fluid collection aspect protocol . Any patient previous diagnosis invasive breast cancer leptomeningeal metastasis undergoes routine procedure associate collection cerebrospinal fluid eligible cerebrospinal fluid collection aspect protocol . All subject must care one member MSKCC Breast Disease Management Team time enrollment . Subjects may receive prior hormonal therapy , cytotoxic chemotherapy , radiation therapy , surgical therapy MSKCC another institution . All subject must 18 year old Subjects eligible without regard sex , racial , ethnic status . It anticipate approximately 99 % patient female . Attending physician authorize obtain informed consent may exercise discretion exclude individual appropriate medical ( e.g. , mentally impaired ) reason . If , pathologic diagnosis , preinvasive invasive breast disease find , patient previously consent blood collection aspect protocol include . For prospective acquisition blood saliva control subject without breast cancer , ineligibility criterion include : A first degree relative ( mother , daughter , sister , father , brother son ) diagnose breast cancer . A personal history breast cancer , lobular carcinoma situ atypia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Family member</keyword>
</DOC>